SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-09-013978
Filing Date
2009-06-15
Accepted
2009-06-15 13:48:05
Documents
4
Period of Report
2009-07-29
Effectiveness Date
2009-06-15

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE 14A c86739def14a.htm DEF 14A 216865
2 GRAPHIC c86739c8673900.gif GRAPHIC 3394
3 GRAPHIC c86739c8673901.gif GRAPHIC 2219
4 GRAPHIC c86739c8673902.gif GRAPHIC 2219
  Complete submission text file 0000950123-09-013978.txt   229694
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15070 | Film No.: 09891618
SIC: 2834 Pharmaceutical Preparations